Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 15/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.49 |
| ▸ | DRD2 | P14416 | 6/20 | 0.46 |
| ▸ | HTR2A | P28223 | 3/20 | 0.46 |
| ▸ | HTR7 | P34969 | 3/20 | 0.46 |
| ▸ | HTR6 | P50406 | 3/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6081283 | 1.00 | HTR1A (0.58) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL6081549 | 1.00 | HTR1A (0.58) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL6628211 | 0.87 | HTR1A (0.65) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL7129070 | 0.82 | HTR1A (0.76) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL7125110 | 0.82 | HTR1A (0.76) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL7120812 | 0.81 | HTR1A (0.59) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL6629048 | 0.81 | HTR1A (0.59) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL5766463 | 0.79 | HTR1A (0.59) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL6105713 | 0.78 | HTR1A (0.57) | HTR1ASLC6A4DRD2HTR2AHTR7 | |
| SCHEMBL6628980 | 0.77 | HTR1A (0.66) | HTR1ASLC6A4DRD2HTR2AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6903110-B2 | Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2005-06-07 | — | — | US | claimed |
| US-20030078268-A1 | Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2003-04-24 | — | — | US | claimed |
| WO-2003010169-A1 | ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7, 8-DIHYDRO-6H-5-OXA-1-AZA-PHENANTHRENE | WYETH (US) | 2003-02-06 | — | — | WO | claimed |
| US-7030245-B2 | Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenathrene | WYETH (US) | 2006-04-18 | — | — | US | disclosed |
| US-20050228010-A1 | Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2005-10-13 | — | — | US | disclosed |
| US-6930109-B2 | Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2005-08-16 | — | — | US | disclosed |
| US-6903110-B2 | Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2005-06-07 | — | — | US | disclosed |
| US-20040235851-A1 | Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH | 2004-11-25 | — | — | US | disclosed |
| US-20030078268-A1 | Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | WYETH (US) | 2003-04-24 | — | — | US | disclosed |
| WO-2003010169-A1 | ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7, 8-DIHYDRO-6H-5-OXA-1-AZA-PHENANTHRENE | WYETH (US) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078268-A1 | Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | TPH1, CYP19A1, HSD3B1 | HTR1A 13/4885SLC6A4 208/4885DRD2 66/4885 |
| US-20040235851-A1 | Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | TPH1, CYP19A1, HSD3B1 | HTR1A 13/4885SLC6A4 216/4885DRD2 66/4885 |
| US-20050228010-A1 | Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene | HTR5A, TPH1, CYP19A1 | HTR1A 18/4885SLC6A4 193/4885DRD2 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.